跳轉至內容
Merck
全部照片(1)

Key Documents

SML1362

Sigma-Aldrich

L755507

≥98% (HPLC)

同義詞:

4-[[[(己基氨基)羰基]氨基] -N-[4-[2-[[((2S)-2-羟基-3-(4-羟基苯氧基)丙基]氨基]乙基]苯基]-苯磺酰胺, L-755,507

登入查看組織和合約定價


About This Item

經驗公式(希爾表示法):
C30H40N4O6S
CAS號碼:
分子量::
584.73
分類程式碼代碼:
12352200
PubChem物質ID:
NACRES:
NA.77

品質等級

化驗

≥98% (HPLC)

形狀

powder

顏色

white to beige

溶解度

DMSO: 20 mg/mL, clear

儲存溫度

2-8°C

SMILES 字串

OC1=CC=C(OC[C@@H](O)CNCCC2=CC=C(NS(C3=CC=C(NC(NCCCCCC)=O)C=C3)(=O)=O)C=C2)C=C1

InChI

1S/C30H40N4O6S/c1-2-3-4-5-19-32-30(37)33-24-10-16-29(17-11-24)41(38,39)34-25-8-6-23(7-9-25)18-20-31-21-27(36)22-40-28-14-12-26(35)13-15-28/h6-17,27,31,34-36H,2-5,18-22H2,1H3,(H2,32,33,37)/t27-/m0/s1

InChI 密鑰

NYYJKMXNVNFOFQ-MHZLTWQESA-N

一般說明

L755507是4-酰基氨基苯磺酰胺的一种衍生物。

應用

L755507显示出具有提高CRISPR基因组编辑效率的作用。欲了解其他CRISPR增强剂小分子,请访问 sigma.com/CRISPR-enhancers

生化/生理作用

L755507可以激活人脂肪组织脂解。L755507也促进膀胱松弛。
L755507是一种有效的β3-肾上腺素能受体部分激动剂。
L755507是一种有效的β3-肾上腺素能受体部分激动剂,对β3受体的EC50值为0.43 nM,对β3的选择性相比β1和β2肾上腺素能受体结合高出440倍。L755507增强人诱导多能干细胞(iPSCs)中CRISPR介导的同源重组修复(HDR)效率,GFP插入效率相比对照细胞增加了2倍。

儲存類別代碼

11 - Combustible Solids

水污染物質分類(WGK)

WGK 3

閃點(°F)

Not applicable

閃點(°C)

Not applicable


分析證明 (COA)

輸入產品批次/批號來搜索 分析證明 (COA)。在產品’s標籤上找到批次和批號,寫有 ‘Lot’或‘Batch’.。

已經擁有該產品?

您可以在文件庫中找到最近購買的產品相關文件。

存取文件庫

客戶也查看了

E R Parmee et al.
Bioorganic & medicinal chemistry letters, 8(9), 1107-1112 (1999-01-01)
A study of 4-acylaminobenzenesulfonamides in a cloned human beta 3 adrenergic receptor assay resulted in the discovery of n-hexylurea, L-755,507 (22). This 0.43 nM beta 3 agonist, which is > 440-fold selective over both beta 1 and beta 2 binding
Tools to study β 3-adrenoceptors.
Vrydag W and Michel M C
Naunyn-Schmiedeberg'S Archives of Pharmacology, 374(5-6), 385-398 (2007)
Dana S Hutchinson et al.
British journal of pharmacology, 135(8), 1903-1914 (2002-04-18)
1. This study characterizes the mouse beta(3a)-adrenoceptor (AR) and the splice variant of the beta(3)-AR (beta(3b)-AR) expressed in Chinese hamster ovary cells (CHO-K1). 2. Stable clones with high (approximately 1200), medium (approximately 500) or low receptor expression (approximately 100 fmol
Masaaki Sato et al.
Molecular pharmacology, 74(5), 1417-1428 (2008-08-08)
This study identifies signaling pathways activated by the beta(2)-/beta(3)-adrenoceptor (AR) agonist zinterol, the selective beta(3)-AR agonist L755507, and the selective beta(3)-AR antagonist L748337 in CHO-K1 cells expressing human beta(3)-adrenoceptors. Zinterol and L755507 caused a robust concentration-dependent increase in cAMP accumulation
Chen Yu et al.
Cell stem cell, 16(2), 142-147 (2015-02-07)
The bacterial CRISPR-Cas9 system has emerged as an effective tool for sequence-specific gene knockout through non-homologous end joining (NHEJ), but it remains inefficient for precise editing of genome sequences. Here we develop a reporter-based screening approach for high-throughput identification of

文章

The CRISPR-Cas9 system is an RNA-guided genome-editing tool that provides researchers a simple, easy, and quick way to modify the genomes of various organisms.

我們的科學家團隊在所有研究領域都有豐富的經驗,包括生命科學、材料科學、化學合成、色譜、分析等.

聯絡技術服務